Table 2 Participant characteristics
| Â | Total |
|---|---|
Gender n (%) | |
 Female | 19 (57.6) |
 Male | 14 (42.4) |
 Age M (SD) | 80.18 (8.27) |
Marital status n (%) | |
 Married | 14 (42.4) |
 Widowed | 17 (51.5) |
 Divorced | 2 (6.1) |
Residing n (%) | |
 Community | 30 (90.9) |
 Residential Facility | 3 (9.2) |
Ethnicity n (%) | |
 White (British) | 28 (84.8) |
 White (other) | 2 (6.1) |
 Black | 1 (3) |
 Asian | 2 (6.1) |
Dementia diagnosis n (%) | |
 Alzheimer’s Disease | 13 (39.4) |
 Vascular Dementia | 5 (15.2) |
 Dementia of mixed etiology | 7 (21.2) |
 Unknown sub-type | 8 (24.2) |
Time since diagnosis n (%) | |
  < 1 year | 8 (24.2) |
 1– 2 years | 3 (9.1) |
 2– 3 years | 8 (24.2) |
  > 3 years | 6 (18.2) |
 Unknown | 8 (24.2) |
Cholinesterase inhibitors n (%) | |
 None | 17 (51.5) |
 Donepezil | 4 (12.1) |
 Memantine | 6 (18.2) |
 Rivastigmine | 3 (9.1) |
 Galantamine | 2 (6.1) |
 Donepezil and Memantine | 1 (3) |
Other psychotropic medication n (%) | |
 None | 27 (81.8) |
 Anti-depressant | 6 (18.2) |